NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

IndexRUT P/E- EPS (ttm)-1.48 Insider Own11.76% Shs Outstand37.03M Perf Week2.39%
Market Cap301.76M Forward P/E- EPS next Y-0.70 Insider Trans-25.51% Shs Float32.67M Perf Month18.98%
Enterprise Value471.88M PEG- EPS next Q-0.10 Inst Own67.05% Short Float7.03% Perf Quarter59.80%
Income-49.40M P/S2.32 EPS this Y-515.62% Inst Trans1.23% Short Ratio9.44 Perf Half Y6.96%
Sales130.31M P/B135.38 EPS next Y47.37% ROA-18.46% Short Interest2.30M Perf YTD9.69%
Book/sh0.06 P/C55.68 EPS next 5Y- ROE-83.58% 52W High8.63 -5.56% Perf Year66.67%
Cash/sh0.15 P/FCF- EPS past 3/5Y- 86.82% ROIC-28.57% 52W Low3.68 121.51% Perf 3Y-19.47%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-9.24% -25.46% Gross Margin33.45% Volatility3.25% 3.84% Perf 5Y5.30%
Dividend TTM- EV/Sales3.62 EPS Y/Y TTM38.42% Oper. Margin-9.26% ATR (14)0.31 Perf 10Y-43.52%
Dividend Ex-Date- Quick Ratio1.59 Sales Y/Y TTM6.88% Profit Margin-37.91% RSI (14)67.11 Recom1.67
Dividend Gr. 3/5Y- - Current Ratio2.71 EPS Q/Q-209.93% SMA207.62% Beta0.66 Target Price10.00
Payout0.00% Debt/Eq2.75 Sales Q/Q-1.54% SMA5014.50% Rel Volume0.60 Prev Close8.19
Employees524 LT Debt/Eq2.64 EarningsApr 03 AMC SMA20026.55% Avg Volume243.34K Price8.15
IPOFeb 15, 1996 Option/ShortYes / Yes EPS/Sales Surpr.-213.33% 5.73% Trades Volume145,871 Change-0.49%
Date Action Analyst Rating Change Price Target Change
May-21-25Initiated William Blair Outperform
Sep-05-24Initiated Craig Hallum Buy $8
Aug-28-24Downgrade Barrington Research Outperform → Mkt Perform
Mar-20-23Downgrade Stephens Overweight → Equal-Weight $11 → $2
Jun-17-25 07:00AM
Jun-12-25 07:00AM
May-27-25 07:00AM
Apr-24-25 11:30AM
09:30AM
07:00AM Loading…
Apr-22-25 07:00AM
Apr-16-25 04:05PM
Apr-14-25 07:00AM
Apr-05-25 12:10PM
Apr-04-25 07:09AM
03:01AM
Apr-03-25 07:43PM
05:20PM
04:17PM
04:05PM
05:15PM Loading…
Mar-31-25 05:15PM
Mar-27-25 04:05PM
Mar-17-25 07:00AM
Mar-07-25 09:55AM
07:20AM
Feb-26-25 04:05PM
Feb-03-25 07:00AM
Jan-22-25 09:36AM
Jan-17-25 05:24PM
Jan-07-25 09:00AM
Jan-06-25 04:05PM
Jan-03-25 09:44AM
02:00AM
Jan-02-25 05:15PM
04:15PM
04:05PM Loading…
04:05PM
Jan-01-25 07:01AM
Dec-29-24 05:00AM
Dec-19-24 04:05PM
07:00AM
Dec-12-24 10:03AM
Nov-26-24 04:05PM
Nov-21-24 04:17PM
Nov-15-24 08:44AM
Nov-12-24 04:05PM
Nov-07-24 07:00AM
Nov-04-24 07:00AM
Oct-17-24 07:30AM
Oct-07-24 09:12PM
01:00AM
Oct-04-24 07:52AM
07:30AM
07:20AM
Oct-03-24 04:05PM
Oct-01-24 07:00AM
Sep-25-24 04:05PM
Sep-19-24 07:00AM
Sep-12-24 04:05PM
07:00AM
Sep-10-24 07:00AM
Sep-06-24 04:05PM
Sep-05-24 04:05PM
Aug-29-24 07:00AM
Aug-27-24 11:59PM
Aug-26-24 05:23PM
Aug-09-24 05:51PM
Jul-26-24 03:30AM
Jul-11-24 02:51AM
Jul-01-24 08:00AM
May-22-24 04:16PM
May-16-24 04:45PM
May-08-24 12:26PM
May-03-24 03:31AM
02:44AM
Apr-22-24 10:59AM
10:29AM
Apr-19-24 04:30PM
Apr-11-24 02:21AM
Apr-01-24 08:00AM
Mar-26-24 04:30PM
Mar-21-24 12:40PM
Mar-20-24 07:30AM
07:00AM
Feb-16-24 04:05PM
Feb-06-24 09:49AM
Jan-30-24 12:20AM
Jan-12-24 04:43PM
Jan-08-24 03:05AM
Jan-05-24 08:00AM
Dec-13-23 07:30AM
Nov-20-23 04:05PM
Nov-17-23 06:04PM
Oct-24-23 07:48AM
Oct-18-23 04:05PM
Oct-17-23 05:00AM
Oct-10-23 04:05PM
08:43AM
Sep-28-23 10:00AM
Sep-01-23 10:44AM
Aug-31-23 10:15PM
08:50AM
07:54AM
07:30AM
Aug-22-23 04:06PM
04:05PM
Lifecore Biomedical, Inc. engages in the development and manufacturing of pharmaceuticals products and services. It focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The company was founded by Otto Sartorius in 1965 and is headquartered in Chaska, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
English Aron R.10% OwnerMay 27 '25Sale6.501,139,5047,411,562414,599May 28 08:06 PM
English Aron R.10% OwnerMay 28 '25Sale7.12150,4191,071,555264,180May 28 08:06 PM
English Aron R.10% OwnerMay 23 '25Sale6.7596,137649,3861,554,103May 28 08:06 PM
English Aron R.10% OwnerMay 13 '25Sale7.0012,33486,3531,650,240May 16 11:28 AM
English Aron R.10% OwnerMay 12 '25Sale7.0345,698321,4261,662,574May 12 06:58 PM
English Aron R.10% OwnerMay 08 '25Sale7.005,09835,6931,708,972May 12 06:58 PM
English Aron R.10% OwnerMay 09 '25Sale7.007004,9001,708,272May 12 06:58 PM
English Aron R.10% OwnerMay 05 '25Sale7.0824,543173,8311,730,618May 07 09:09 PM
English Aron R.10% OwnerMay 07 '25Sale7.0115,847111,0991,714,070May 07 09:09 PM
English Aron R.10% OwnerMay 06 '25Sale7.057014,9401,729,917May 07 09:09 PM
Josephs PaulChief Executive OfficerJan 08 '25Buy5.7417,00097,580559,717Jan 08 04:10 PM
Morberg John DFormer officerNov 20 '24Proposed Sale7.1710,00071,691Nov 20 10:14 AM
Morberg John DFormer officerNov 11 '24Proposed Sale6.6430,990205,803Nov 12 02:43 PM
Morberg John DFormer officerOct 31 '24Proposed Sale5.6840,989232,888Oct 31 04:18 PM
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerOct 03 '24Buy4.10169,753695,9872,607,433Oct 07 08:45 PM
WYNNEFIELD PARTNERS SMALL CAP 10% OwnerOct 03 '24Buy4.10122,930504,0132,095,783Oct 07 08:45 PM
Morberg John DFormer officerOct 07 '24Proposed Sale5.1912,61765,482Oct 07 01:03 PM
Morberg John DFormer officerSep 20 '24Proposed Sale5.4915,00082,350Sep 20 04:00 PM